T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
TransDigm Group
TDG
$68.9B
| $92.6M | 0.02% |
176,479
+1,407
| +0.8% | +$840K |
|
502
OneMain Financial
OMF
$7.51B
| $91.9M | 0.02% |
3,112,696
+2,760,751
| +784% | +$102M |
|
|
OLK
503
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $91.8M | 0.02% |
7,562,693
-2,108,146
| -22% | -$32.3M |
|
504
Casella Waste Systems
CWST
$5.79B
| $91.8M | 0.02% |
1,201,851
-48,711
| -4% | -$3.91M |
|
505
Target
TGT
$70.6B
| $90.8M | 0.01% |
611,894
-104
| -0% | -$16.7K |
|
506
Truist Financial
TFC
$64.7B
| $90.1M | 0.01% |
2,070,160
+406
| +0% | +$19.5K |
|
507
Capital One
COF
$137B
| $89.6M | 0.01% |
972,149
-612,918
| -39% | -$65.3M |
|
508
Kymera Therapeutics
KYMR
$9.51B
| $89.2M | 0.01% |
4,097,712
-1,126,974
| -22% | -$29.7M |
|
509
Gartner
IT
$11.6B
| $88.9M | 0.01% |
321,215
-10,088
| -3% | -$2.83M |
|
510
Lantheus
LNTH
$6.59B
| $88.3M | 0.01% |
1,255,671
-1,061,220
| -46% | -$80.4M |
|
511
Gen Digital
GEN
$17.7B
| $87.9M | 0.01% |
4,362,093
+2,848,401
| +188% | +$65.9M |
|
|
LPRO
512
DELISTED
Open Lending Corp
LPRO
| $87.8M | 0.01% |
10,921,736
+4,522,048
| +71% | +$45.7M |
|
513
ScottsMiracle-Gro
SMG
$3.59B
| $87.5M | 0.01% |
2,046,743
+385,514
| +23% | +$27.7M |
|
514
Haleon
HLN
$43.2B
| $87.4M | 0.01% |
+14,354,094
| New | +$92.9M |
|
515
Braze
BRZE
$3.36B
| $87.3M | 0.01% |
2,506,050
+1,658,690
| +196% | +$70M |
|
516
iRhythm Holdings
IRTC
$4.06B
| $86.8M | 0.01% |
692,578
+30,393
| +5% | +$4.39M |
|
517
Guardant Health
GH
$21.4B
| $85.8M | 0.01% |
1,594,599
+23,857
| +2% | +$1.22M |
|
|
RNAM
518
DELISTED
Avidity Biosciences
RNAM
| $84.4M | 0.01% |
5,169,023
-2,714,102
| -34% | -$51.9M |
|
519
Factset
FDS
$10.2B
| $84.3M | 0.01% |
210,630
+9,672
| +5% | +$4.09M |
|
520
Waste Management
WM
$89.6B
| $84.1M | 0.01% |
524,730
-1,528
| -0.3% | -$252K |
|
|
SAGE
521
DELISTED
Sage Therapeutics
SAGE
| $83.8M | 0.01% |
2,140,411
+62,877
| +3% | +$2.43M |
|
522
Xencor
XNCR
$1.71B
| $83.4M | 0.01% |
3,209,611
-3,389,460
| -51% | -$97.1M |
|
523
Raymond James Financial
RJF
$34.8B
| $83.2M | 0.01% |
842,139
-2,015,526
| -71% | -$204M |
|
524
Pool Corp
POOL
$7.29B
| $82.8M | 0.01% |
260,103
-44,818
| -15% | -$16M |
|
525
Cognizant
CTSH
$26.7B
| $82.7M | 0.01% |
1,440,342
+18,667
| +1% | +$1.22M |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.